Novel 3′-deoxy analogs of the anti-HBV agent entecavir: Synthesis of enantiomers from a single chiral epoxide

Tetrahedron Letters

Volumn 45, Issue 4, 2004, Pages 739-742

  Ruediger, Edward ^a   Martel, Alain ^a   Meanwell, Nicholas ^a   Solomon, Carola ^a   Turmel, Brigitte ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Carbacyclic nucleosides; Entecavir; Epoxide rearrangement; HBV

Indexed keywords

ANTIVIRUS AGENT; CARBOCYCLIC NUCLEOSIDE; CYCLOPENTENE DERIVATIVE; ENTECAVIR; EPOXIDE;

ANTIVIRAL ACTIVITY; ARTICLE; CHIRALITY; DRUG SYNTHESIS; ENANTIOMER; ENANTIOSELECTIVITY; HEPATITIS B VIRUS;

HEPATITIS B VIRUS;

EID: 0347418219     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2003.11.052     Document Type: Article

References (33)

1. Regev A., Schiff E.R. Adv. Int. Med. 46:2001;107.
2. Maddrey W.C. Clin. Lab. 47:2001;51.
3. Perillo R.P., Schiff E.R., Davis G.L., Bodenheimer H.C. Jr., Lindsay K., Payne J., Dienstag J.L., O'Brien C., Tamburro C., Jacobson I.M. N. Engl. J. Med. 323:1990;295.
4. Wong D.K., Cheung A.M., O'Rourke K., Naylor C.D., Detsky A.S., Heathcote J. Ann. Int. Med. 119:1993;312.
5. Tipples G.A., Ma M.M., Fischer K.P., Bain V.G., Kneteman N.M., Tyrrell D.L.J. Hepatology. 24:1996;714.
6. Starrett J.E. Jr., Tortolani D.R., Hitchcock M.J., Martin J.C., Mansuri M.M. Antiviral Res. 19:1992;267 Perrillo R., Schiff E., Yoshida E., Statler A., Hirsch K., Wright T., Gutfreund K., Lamy P., Murray A. Hepatology. 32:2000;129.
7. Starrett J.E. Jr., Tortolani D.R., Hitchcock M.J., Martin J.C., Mansuri M.M. Antiviral Res. 19:1992;267 Perrillo R., Schiff E., Yoshida E., Statler A., Hirsch K., Wright T., Gutfreund K., Lamy P., Murray A. Hepatology. 32:2000;129.
8. Zoulim F. J. Clin. Virol. 21:2001;243.
9. Lin T.S., Luo M.X., Liu M.C., Zhu Y.L., Gullen E., Dutschman G.E., Cheng Y.C. J. Med. Chem. 39:1996;1757 (b) Ma T., Pai S.B., Zhu Y.L., Lin J.S., Shanmuganathan K., Du J., Wang C., Kim H., Newton M.G., Cheng Y.C., Chu C.K. J. Med. Chem. 39:1996;2835 (c) Kumar R., Nath M., Tyrrell D.L.J. J. Med. Chem. 45:2002;2032.
10. Lin T.S., Luo M.X., Liu M.C., Zhu Y.L., Gullen E., Dutschman G.E., Cheng Y.C. J. Med. Chem. 39:1996;1757 (b) Ma T., Pai S.B., Zhu Y.L., Lin J.S., Shanmuganathan K., Du J., Wang C., Kim H., Newton M.G., Cheng Y.C., Chu C.K. J. Med. Chem. 39:1996;2835 (c) Kumar R., Nath M., Tyrrell D.L.J. J. Med. Chem. 45:2002;2032.
11. Lin T.S., Luo M.X., Liu M.C., Zhu Y.L., Gullen E., Dutschman G.E., Cheng Y.C. J. Med. Chem. 39:1996;1757 (b) Ma T., Pai S.B., Zhu Y.L., Lin J.S., Shanmuganathan K., Du J., Wang C., Kim H., Newton M.G., Cheng Y.C., Chu C.K. J. Med. Chem. 39:1996;2835 (c) Kumar R., Nath M., Tyrrell D.L.J. J. Med. Chem. 45:2002;2032.
12. (a) Innaimo S.F., Seifer M., Bisacchi G.S., Standring D.N., Zahler R., Colonno R.J. Antimicrob. Agents Chemother. 41:1997;1444
13. (b) Genovesi E.V., Lamb L., Medina I., Tayler D., Seifer M., Innaimo S., Colonno R.J., Standring D.N., Clark J.M. Antimicrob. Agents Chemother. 42:1998;3209.
14. Bisacchi G.S., Chao S.T., Bachand C., Daris J.-P., Innaimo S.F., Jacobs G.A., Kocy O., Lapointe P., Martel A., Merchant Z., Slusarchyk W.A., Sundeen J.E., Young M.G., Colonno R.J., Zahler R. Bioorg. Med. Chem. Lett. 7:1997;127.
15. Borthwick A.D., Kirk B.E., Biggadike K., Exall A.M., Roberts S.M., Knight D.J., Coates J.A.V., Ryan D.M. J. Med. Chem. 34:1991;907.
16. (a) Various examples of base-catalyzed rearrangements of functionalized cyclopentene epoxides have recently been reported; Camps P., Colet G., Font-Bardia M., Munoz-Torrero V., Solans X., Vásquez S. Tetrahedron. 58:2002;3473
17. (b) Hodgson D.M., Witherington J., Moloney B.A. Tetrahedron: Asymmetry. 5:1994;337
18. (c) Milne D., Murphy P.J. J. Chem. Soc., Chem. Commun. 1993;884
19. (d) Asami M. Bull. Chem. Soc. Jpn. 63:1990;1402.
20. Kissel C.L., Rickborn B. J. Org. Chem. 37:1972;2060 Rickborn B., Thummel R.P. J. Org. Chem. 34:1969;3583.
21. Kissel C.L., Rickborn B. J. Org. Chem. 37:1972;2060 Rickborn B., Thummel R.P. J. Org. Chem. 34:1969;3583.
22. 3) δ 7.37-7.28 (m, 5H), 5.92 (s, 1H), 4.64 (m, 1H), 4.61 (m, 1H), 4.55 (s, 2H), 4.15 (s, 2H), 2.74 (dt, J=7.1 , 13.6 Hz, 1H), 2.09 (br s, 1H), 1.61 (dt, J=4.7 , 13. 6 Hz, 1H), 0.92 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H).
23. 3) δ 7.40-7.29 (m, 5H), 5.90 (d, J=5.5 Hz, 1H), 5.83 (d, J=5.5 Hz, 1H), 4.62 (ab d, J=12.2 Hz, 1H), 4.56 (ab d, J=12.2 Hz, 1H), 4.56-4.51 (m, 2H), 3.79 (dd, J=4.7 , 9.0 Hz, 1H), 3.63 (dd, J=7.1 , 9.0 Hz, 1H), 2.13 (quintet, J=5.5 Hz, 1H), 1.99 (br s, 1H), 0.90 (s, 9H), 0.09 (s, 3H), 0.07 (s, 3H).
24. Stork G., Kowalski C., Garcia G. J. Am. Chem. Soc. 97:1975;3258 Piancatelli G., Scettri A. Synthesis. 1977;116.
25. Stork G., Kowalski C., Garcia G. J. Am. Chem. Soc. 97:1975;3258 Piancatelli G., Scettri A. Synthesis. 1977;116.
26. 3) δ 7.74-7.70 (m, 5H), 7.48-7.30 (m, 10H), 5.76 (s, 1H), 4.63 (t, J=7.1 Hz, 1H), 4.54 (t, J=4.5 Hz, 1H), 4.51 (s, 2H), 4.12 (s, 2H), 2.56 (dt, J=7.1 , 13.3 Hz, 1H), 1.76 (dt, J=5.9 , 12.9 Hz, 1H), 1.10 (s, 9H), 0.93 (s, 9H), 0.08 (s, 6H).
27. Rasmussen J.R., Slinger C.R., Kordish R.J., Newmann-Evans D.D. J. Org. Chem. 46:1981;4843.
28. Stork G., Paterson I., Lee F.K.C. J. Am. Chem. Soc. 104:1982;4686.
29. (a) Dess D.B., Martin J.C. J. Am. Chem. Soc. 113:1991;7277
30. (b) Ireland R.E., Liu L. J. Org. Chem. 58:1993;2899.
31. Madhaven G.V., McGee D.P.C., Rydzewski R.M., Boehme R., Martin J.C., Prisbe E.J. J. Med. Chem. 31:1988;1798.
32. Sharpless K.B., Lauer R.F. J. Am. Chem. Soc. 95:1973;2697.
33. HepG2.2.15 human liver cells, which harbor integrated HBV genomes, secrete substantial amounts of infectious HBV particles bearing viral DNA genomes into the medium. Antiviral effects were scored as reductions in the amount of HBV DNA present in the media after treatment of the cells with drug for 9 days. HBV DNA was released from secreted virus particles by alkali treatment, after which it was immobilized onto membranes and quantified by hybridization with a radiolabelled HBV DNA probe.